These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26460286)

  • 1. Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.
    Peeters Weem SM; Teraa M; de Borst GJ; Verhaar MC; Moll FL
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):775-83. PubMed ID: 26460286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials.
    Teraa M; Sprengers RW; van der Graaf Y; Peters CE; Moll FL; Verhaar MC
    Ann Surg; 2013 Dec; 258(6):922-9. PubMed ID: 23426345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Cell Therapy for Peripheral Arterial Disease: Systematic Review and Meta-Analysis of Randomized, Nonrandomized, and Noncontrolled Studies.
    Rigato M; Monami M; Fadini GP
    Circ Res; 2017 Apr; 120(8):1326-1340. PubMed ID: 28096194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
    Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites.
    Wang SK; Green LA; Gutwein AR; Drucker NA; Babbey CM; Gupta AK; Fajardo A; Motaganahalli RL; Wilson MG; Murphy MP
    J Vasc Surg; 2018 Aug; 68(2):560-566. PubMed ID: 29503004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
    Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
    J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
    Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
    J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiosome-directed revascularization in patients with critical limb ischemia.
    Jongsma H; Bekken JA; Akkersdijk GP; Hoeks SE; Verhagen HJ; Fioole B
    J Vasc Surg; 2017 Apr; 65(4):1208-1219.e1. PubMed ID: 28342514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis.
    Kokkinidis DG; Arfaras-Melainis A; Giannopoulos S; Katsaros I; Jawaid O; Jonnalagadda AK; Parikh SA; Secemsky EA; Giri J; Kumbhani DJ; Armstrong EJ
    Vasc Med; 2020 Apr; 25(2):106-117. PubMed ID: 31964311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
    Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
    J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital outcomes in patients with critical limb ischemia and end-stage renal disease after revascularization.
    Meyer A; Lang W; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2016 Apr; 63(4):966-73. PubMed ID: 26843355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial.
    Teraa M; Sprengers RW; Schutgens RE; Slaper-Cortenbach IC; van der Graaf Y; Algra A; van der Tweel I; Doevendans PA; Mali WP; Moll FL; Verhaar MC
    Circulation; 2015 Mar; 131(10):851-60. PubMed ID: 25567765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and outcome after failed infrainguinal endovascular and open revascularization in patients with chronic limb ischemia.
    Dosluoglu HH; Lall P; Blochle R; Harris LM; Dryjski ML
    J Vasc Surg; 2013 Jul; 58(1):98-104.e1. PubMed ID: 23683380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
    Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
    Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes After Endovascular Revascularization in Octogenarians and Non-Octogenarians With Critical Limb Ischemia.
    Uhl C; Steinbauer M; Torsello G; Bisdas T;
    J Endovasc Ther; 2017 Aug; 24(4):471-477. PubMed ID: 28578624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival.
    Suckow BD; Kraiss LW; Schanzer A; Stone DH; Kalish J; DeMartino RR; Cronenwett JL; Goodney PP;
    J Vasc Surg; 2015 Jan; 61(1):126-33. PubMed ID: 25037607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Death and Amputation with Use of Paclitaxel-Coated Balloons in the Infrapopliteal Arteries for Treatment of Critical Limb Ischemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Katsanos K; Spiliopoulos S; Kitrou P; Krokidis M; Paraskevopoulos I; Karnabatidis D
    J Vasc Interv Radiol; 2020 Feb; 31(2):202-212. PubMed ID: 31954604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
    Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
    J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.